eP201: A phase 2 clinical trial evaluating the safety and efficacy of delandistrogene moxeparvovec for treating patients with Duchenne muscular dystrophy
Saved in:
Published in: | Genetics in medicine Vol. 24; no. 3; p. S124 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Inc
01-03-2022
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
ISSN: | 1098-3600 1530-0366 |
---|---|
DOI: | 10.1016/j.gim.2022.01.237 |